A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...
GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy and Mounjaro — were linked to improved survival among colon cancer patients in a new observational study from UC San Diego.
Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.
MedPage Today on MSN
Novel GLP-1 Drug on Attack Path Against Very High Triglycerides
During an AHA press conference, Li explained that each component of the triple-receptor agonist compensates for side effects ...
MedPage Today on MSN
GI Risks Similar Among GLP-1 Drugs, but Higher Than With SGLT-2 Inhibitors
Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission yeast as a model, have shown that the new TOR inhibitor rapalink-1 prolongs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback